Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review

A Prelaj, V Miskovic, M Zanitti, F Trovo, C Genova… - Annals of …, 2024 - Elsevier
Background The widespread use of immune checkpoint inhibitors (ICIs) has revolutionised
treatment of multiple cancer types. However, selecting patients who may benefit from ICI …

Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond

Z Zhou, J Wang, J Wang, S Yang, R Wang, G Zhang… - Molecular Cancer, 2024 - Springer
Tumor immune microenvironment (TIME) consists of intra-tumor immunological components
and plays a significant role in tumor initiation, progression, metastasis, and response to …

Interferon-stimulated neutrophils as a predictor of immunotherapy response

M Benguigui, TJ Cooper, P Kalkar, S Schif-Zuck… - Cancer Cell, 2024 - cell.com
Despite the remarkable success of anti-cancer immunotherapy, its effectiveness remains
confined to a subset of patients—emphasizing the importance of predictive biomarkers in …

Beyond CTLA-4 and PD-1 inhibition: novel immune checkpoint molecules for melanoma treatment

DC Ziogas, C Theocharopoulos, PP Lialios, D Foteinou… - Cancers, 2023 - mdpi.com
Simple Summary Although the incorporation of immune checkpoint inhibitors (ICIs) in
melanoma treatment has significantly improved prognosis for patients with advanced …

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells

CR Chokshi, MV Shaikh, B Brakel, MA Rossotti… - Nature Medicine, 2024 - nature.com
Resistance to genotoxic therapies and tumor recurrence are hallmarks of glioblastoma
(GBM), an aggressive brain tumor. In this study, we investigated functional drivers of post …

Informing immunotherapy with multi-omics driven machine learning

Y Li, X Wu, D Fang, Y Luo - npj Digital Medicine, 2024 - nature.com
Progress in sequencing technologies and clinical experiments has revolutionized
immunotherapy on solid and hematologic malignancies. However, the benefits of …

Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response

CJM Williams, AM Peddle, PM Kasi… - Nature Reviews …, 2024 - nature.com
Approximately 15% of locally advanced colorectal cancers (CRC) have DNA mismatch
repair deficiency (dMMR), resulting in high microsatellite instability and a high tumour …

Germline stem cells in human

H Cheng, D Shang, R Zhou - Signal transduction and targeted therapy, 2022 - nature.com
The germline cells are essential for the propagation of human beings, thus essential for the
survival of mankind. The germline stem cells, as a unique cell type, generate various states …

[HTML][HTML] RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer

Y Luo, W Tian, D Kang, L Wu, H Tang, S Wang… - Journal of Advanced …, 2024 - Elsevier
Introduction Growing interest toward RNA modification in cancer has inspired the
exploration of gene sets related to multiple RNA modifications. However, a comprehensive …

Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity

Y Hu, F Shen, X Yang, T Han, Z Long, J Wen… - Clinical …, 2023 - Springer
Background Previous studies have traditionally attributed the initiation of cancer cells to
genetic mutations, considering them as the fundamental drivers of carcinogenesis. However …